The document discusses the increasing prevalence of counterfeit pharmaceuticals and the challenges in enforcing rights against them, highlighting a 42% increase in seizures and a projected 19% growth in online spending. It emphasizes the need for a new approach that considers the changing tactics of counterfeiters and consumer behavior, advocating for collaboration among various stakeholders. Effective strategies should focus on reducing the ease of business for criminals and educating consumers about the risks of counterfeit goods.